Sovereign Capital Partners completed the investment in Bioscript.

Sovereign Capital Partners, a private equity specialist, completed the investment in Bioscript, a provider of medical communications and regulatory writing services. Financial terms were not disclosed. “We have followed Bioscript for more than seven years and are delighted to be backing this highly skilled team as they look to the future. The market offers real opportunity, and the team are keen to build a significantly larger business in the UK and internationally. We look forward to bringing both our strategic investment and partnership approach," Dominic Dalli, Sovereign Managing Partner.